Cubist Systematic Strategies’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $12.8K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $802K | Buy |
|
|||||
|
2023
Q3 | $73.8K | Sell |
|
|||||
|
2023
Q2 | $2.17M | Sell |
|
|||||
|
2023
Q1 | $3.67M | Buy |
|
|||||
|
2022
Q4 | $5.78M | Buy |
|
|||||
|
2022
Q3 | $5.8M | Sell |
|
|||||
|
2022
Q2 | $9.1M | Buy |
|
|||||
|
2022
Q1 | $659K | Buy |
|
|||||
|
2021
Q4 | $620K | Sell |
|
|||||
|
2021
Q3 | $4.8M | Buy |
|
|||||
|
2021
Q2 | $1.63M | Sell |
|
|||||
|
2021
Q1 | $3.55M | Sell |
|
|||||
|
2020
Q4 | $6.49M | Sell |
|
|||||
|
2020
Q3 | $3.46M | Buy |
|
|||||
|
2020
Q2 | $3K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $865K | Buy |
|
|||||
|
2019
Q3 | $0 | Sell |
|
|||||
|
2019
Q2 | $100K | Buy |
|
|||||
|
2019
Q1 | $50K | Sell |
|
|||||
|
2018
Q4 | $273K | Buy |
|